Scout | Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)

This opportunity is no longer accepting applications.

grant

Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)

This grant opportunity encourages applications to create PET Radiotracers for Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) research. These radiotracers should be suitable for use in human subjects as biomarkers or in developing new drugs. The research should concentrate on new or emerging targets related to neurodegeneration. This can include developing new tracers…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Aging

Dates

Opportunity Released: September 28, 2022

Keywords

Radiotracer development

Alzheimer's disease

AD-related dementias

PET imaging

biomarkers

neurodegeneration

molecular pathways

drug development

human subjects research

biological processes

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers